Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Infantino

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Arthritis Research & Therapy|March 15, 2014
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated systemFrancesca Buzzulini, Amelia Rigon, Paolo Soda, et al.
Journal of Medical Virology|May 31, 2020
COVID-19 pneumonia treated with Sarilumab: A clinical series of eight patientsMaurizio Benucci, Gianfranco Giannasi, Paolo Cecchini, et al.
Journal of Personalized Medicine|July 27, 2022
Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic DiseaseMaurizio Benucci, Arianna Damiani, Edda Russo, et al.
Journal of Personalized Medicine|June 27, 2024
Evaluation of a New Multiparametric Microdot Array-Based Immunoassay Panel for Systemic Autoimmune Disease DiagnosisMaria Infantino, Francesca Pavia, Valentina Grossi, et al.
RMD Open|August 4, 2023
Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysisFrancesca Motta, Nicola Bizzaro, Davide Giavarina, et al.
Therapeutics and Clinical Risk Management|May 6, 2020
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical DataMaurizio Benucci, Arianna Damiani, Francesca Li Gobbi, et al.
Annals of the Rheumatic Diseases|July 8, 2020
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARDMaurizio Benucci, Arianna Damiani, Gianfranco Giannasi, et al.
Annals of the Rheumatic Diseases|August 3, 2021
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli <i>et al</i>Maurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Clinical Chemistry and Laboratory Medicine|November 24, 2004
Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assaySergio Bernardini, Maria Infantino, Lorenza Bellincampi, et al.
Pharmacological Research|July 30, 2022
Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlightedMaurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Arthritis Research & Therapy|March 15, 2014
The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated systemFrancesca Buzzulini, Amelia Rigon, Paolo Soda, et al.
Journal of Medical Virology|May 31, 2020
COVID-19 pneumonia treated with Sarilumab: A clinical series of eight patientsMaurizio Benucci, Gianfranco Giannasi, Paolo Cecchini, et al.
Journal of Personalized Medicine|July 27, 2022
Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic DiseaseMaurizio Benucci, Arianna Damiani, Edda Russo, et al.
Journal of Personalized Medicine|June 27, 2024
Evaluation of a New Multiparametric Microdot Array-Based Immunoassay Panel for Systemic Autoimmune Disease DiagnosisMaria Infantino, Francesca Pavia, Valentina Grossi, et al.
RMD Open|August 4, 2023
Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysisFrancesca Motta, Nicola Bizzaro, Davide Giavarina, et al.
Therapeutics and Clinical Risk Management|May 6, 2020
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical DataMaurizio Benucci, Arianna Damiani, Francesca Li Gobbi, et al.
Annals of the Rheumatic Diseases|July 8, 2020
Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARDMaurizio Benucci, Arianna Damiani, Gianfranco Giannasi, et al.
Annals of the Rheumatic Diseases|August 3, 2021
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli <i>et al</i>Maurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Clinical Chemistry and Laboratory Medicine|November 24, 2004
Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assaySergio Bernardini, Maria Infantino, Lorenza Bellincampi, et al.
Pharmacological Research|July 30, 2022
Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlightedMaurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Pageof 16